News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Yazan Madanat: My Promotion to Associate Professor is effective on Sept 1st, 2024 UT Southwestern Medical Center
utswmed.org
Mar 18, 2024, 19:49

Yazan Madanat: My Promotion to Associate Professor is effective on Sept 1st, 2024 UT Southwestern Medical Center

Quoting Yazan Madanat, Leukemia Director and Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, on X/Twitter:

”Feeling Proud. It’s Official. My Promotion to Associate Professor is effective on Sept 1st, 2024 UT Southwestern Medical Center, UTSW Simmons Cancer Center, UTSW Internal Medicine. Thankful to all the support from my mentees/trainees, colleagues, mentors and division leadership.”

Yazan Madanat: My Promotion to Associate Professor is effective on Sept 1st, 2024 UT Southwestern Medical Center

Source: Yazan Madanat/X

cancer leadership OncoDaily Oncology UT Southwestern Medical Center UTSW Internal Medicine UTSW Simmons Cancer Center Yazan Madanat
Special Coverage
Blog
Jan 28, 2025, 20:25
Hung Trinh: Direct in vivo CAR T cell engineering
Career
Jan 28, 2025, 19:39
Nina Bhardwaj - Candidate for the Nominating Committee of AACR
Blog
Jan 28, 2025, 17:24
Sohila Karem: Attending the Cairo BGICC has been an incredibly enriching experience
Science
Jan 28, 2025, 17:24
Yakup Ergün: With KRAS mutations now targetable, I was reminded of our research on backbone chemotherapy selection
Blog
Jan 28, 2025, 17:24
Estela Rodriguez: Dear FDA, clinical trial diversity is not DEI
Blog
Jan 28, 2025, 17:24
Estela Rodriguez: Registration is open for the 22nd Annual PER Winter Lung Cancer Conference
Science
Jan 28, 2025, 17:24
Manel Esteller: Thrilled to introduce our article on mapping the "Hallmarks of Cancer" in human primary tumors
Blog
Jan 28, 2025, 17:23
Marwan Fakih: Privileged to present R Phase 2 study results of BOT +/- BAL in chemoresistant MSS CRC at ASCO GI25
Insight
Jan 28, 2025, 17:20
Pashtoon Kasi: Very intriguing to see differences of single agent PD1 vs combination with CTLA4
Blog
Jan 28, 2025, 17:20
Melanoma clinical trial ME17 is officially open for enrollment in Canada - Canadian Cancer Trials Group
Blog
Jan 28, 2025, 17:19
EIOC Journal Club virtual roundtable discussion on the Treatment of Endometrial Cancer
Blog
Jan 28, 2025, 17:18
Pashtoon Kasi: Positive thing to look at ASCO each year is the “incremental” gains in survival